Cargando…
Preclinical and clinical advances in transposon-based gene therapy
Transposons derived from Sleeping Beauty (SB), piggyBac (PB), or Tol2 typically require cotransfection of transposon DNA with a transposase either as an expression plasmid or mRNA. Consequently, this results in genomic integration of the potentially therapeutic gene into chromosomes of the desired t...
Autores principales: | Tipanee, Jaitip, Chai, Yoke Chin, VandenDriessche, Thierry, Chuah, Marinee K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715130/ https://www.ncbi.nlm.nih.gov/pubmed/29089466 http://dx.doi.org/10.1042/BSR20160614 |
Ejemplares similares
-
Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy
por: Tipanee, Jaitip, et al.
Publicado: (2022) -
Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons
por: Tipanee, Jaitip, et al.
Publicado: (2020) -
Comprehensive transcriptome-wide analysis of spliceopathy correction of myotonic dystrophy using CRISPR-Cas9 in iPSCs-derived cardiomyocytes
por: Dastidar, Sumitava, et al.
Publicado: (2022) -
Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation
por: Rincon, Melvin Y., et al.
Publicado: (2015) -
Hyperactive PiggyBac Transposons for Sustained and Robust Liver-targeted Gene Therapy
por: Di Matteo, Mario, et al.
Publicado: (2014)